{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:19:24Z","timestamp":1791980364736,"version":"4.4.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011339","name":"Roy and Christine Sturgis Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.neurobiolaging.2020.10.001","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T11:16:14Z","timestamp":1602328574000},"page":"73-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Alzheimer amyloid-\u03b2- peptide disrupts membrane localization of glucose transporter 1 in astrocytes: implications for glucose levels in brain and blood"],"prefix":"10.1016","volume":"97","author":[{"given":"Rachel D.","family":"Hendrix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakeira E.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela K.","family":"Odle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Groves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anti\u00f1o R.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwen V.","family":"Childs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W.","family":"Barger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuroscience.2018.05.002","article-title":"Characterization of impaired cerebrovascular structure in APP\/PS1 mouse brains","volume":"385","author":"Ahn","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbr.2017.12.008","article-title":"Changes in cognition and dendritic complexity following intrathecal methotrexate and cytarabine treatment in a juvenile murine model","volume":"346","author":"Alexander","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00259-014-2919-z","article-title":"Cortical hypermetabolism in MCI subjects: a compensatory mechanism?","volume":"42","author":"Ashraf","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jneumeth.2018.11.005","article-title":"Functional assessments through novel proteomics approaches: application to insulin\/IGF signaling in neurodegenerative disease","volume":"319","author":"Ayyadevara","year":"2019","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archneurol.2010.225","article-title":"Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes","volume":"68","author":"Baker","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tins.2005.01.002","article-title":"Why glucose transport in the brain matters for PET","volume":"28","author":"Barros","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/gerona\/60.4.471","article-title":"Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology","volume":"60","author":"Beeri","year":"2005","journal-title":"J.\u00a0Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib8","doi-asserted-by":"crossref","first-page":"E4502","DOI":"10.1073\/pnas.1317918110","article-title":"Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease","volume":"110","author":"Benzinger","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib9","series-title":"Each Organ Has a Unique Metabolic Profile. Biochemistry","author":"Berg","year":"2002"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","article-title":"Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications","volume":"14","author":"Biessels","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1050-3862(96)00167-2","article-title":"A\u00a0vector for expressing foreign genes in the brains and hearts of transgenic mice","volume":"13","author":"Borchelt","year":"1996","journal-title":"Genet. Anal."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.metabol.2018.03.005","article-title":"The BACE1 product sAPPbeta induces ER stress and inflammation and impairs insulin signaling","volume":"85","author":"Botteri","year":"2018","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib13","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJM199512283332602","article-title":"Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus","volume":"333","author":"Boyle","year":"1995","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1210\/endo-50-6-677","article-title":"Saline hydration and diuresis after adrenalectomy","volume":"50","author":"Bristol","year":"1952","journal-title":"Endocrinology"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.nicl.2018.01.019","article-title":"FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort","volume":"18","author":"Caminiti","year":"2018","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s00259-018-4217-7","article-title":"Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer's disease","volume":"46","author":"Carter","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib17","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3233\/JAD-2012-111880","article-title":"Impaired neuronal insulin signaling precedes Abeta42 accumulation in female AbetaPPsw\/PS1DeltaE9 mice","volume":"29","author":"Chua","year":"2012","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib18","doi-asserted-by":"crossref","first-page":"14770","DOI":"10.1523\/JNEUROSCI.3669-09.2009","article-title":"Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve","volume":"29","author":"Cohen","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/BF00969700","article-title":"Down-regulation of blood-brain glucose transport in the hyperglycemic nonobese diabetic mouse","volume":"20","author":"Cornford","year":"1995","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib20","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/jcbfm.2011.175","article-title":"Brain lactate metabolism: the discoveries and the controversies","volume":"32","author":"Dienel","year":"2012","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/ph11010011","article-title":"The implication of the brain insulin receptor in late onset Alzheimer\u2019s disease dementia","volume":"11","author":"Folch","year":"2018","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib22","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/00004728-198308000-00003","article-title":"Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose","volume":"7","author":"Friedland","year":"1983","journal-title":"J.\u00a0Comput. Assist. Tomogr."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib23","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1001\/archneurol.2010.301","article-title":"Validation of consensus panel diagnosis in dementia","volume":"67","author":"Gabel","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib24","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/clinchem\/27.8.1474","article-title":"More on the meaning of \"blood-brain barrier\"","volume":"27","author":"Gjedde","year":"1981","journal-title":"Clin. Chem."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1126\/science.7027439","article-title":"Blood-brain glucose transfer: repression in chronic hyperglycemia","volume":"214","author":"Gjedde","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1017\/S104161020200844X","article-title":"Diabetes mellitus is a risk factor for vascular dementia, but not for Alzheimer's disease: a population-based study of the oldest old","volume":"14","author":"Hassing","year":"2002","journal-title":"Int. Psychogeriatr"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib27","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/WNL.49.5.1306","article-title":"Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study","volume":"49","author":"Heitner","year":"1997","journal-title":"Neurology"},{"issue":"Spec No 2","key":"10.1016\/j.neurobiolaging.2020.10.001_bib28","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1259\/bjr\/97295129","article-title":"Positron emission tomography imaging in dementia","volume":"80","author":"Herholz","year":"2007","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib29","first-page":"1920","article-title":"FDG PET imaging in patients with pathologically verified dementia","volume":"41","author":"Hoffman","year":"2000","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00193951","article-title":"Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease","volume":"425","author":"Horwood","year":"1994","journal-title":"Virchows Arch."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib31","doi-asserted-by":"crossref","first-page":"e95913","DOI":"10.1172\/jci.insight.95913","article-title":"Blunted rise in brain glucose levels during hyperglycemia in adults with obesity and T2DM","volume":"2","author":"Hwang","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib32","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.cell.2016.03.033","article-title":"Myeloid-cell-derived VEGF maintains brain glucose uptake and limits cognitive impairment in obesity","volume":"165","author":"Jais","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib33","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","article-title":"Increased risk of type 2 diabetes in Alzheimer disease","volume":"53","author":"Janson","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib34","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.2337\/db11-1498","article-title":"Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet","volume":"61","author":"Jeon","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib35","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1471-4159.1989.tb07399.x","article-title":"Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease","volume":"53","author":"Kalaria","year":"1989","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijdevneu.2017.03.011","article-title":"Cognitive deficits associated with a high-fat diet and insulin resistance are potentiated by overexpression of ecto-nucleotide pyrophosphatase phosphodiesterase-1","volume":"64","author":"Kasper","year":"2018","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib37","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1468-1331.2011.03570.x","article-title":"Glucose metabolism in sporadic Creutzfeldt-Jakob disease: a statistical parametric mapping analysis of (18) F-FDG PET","volume":"19","author":"Kim","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-1326-8-15","article-title":"Normal cognition in transgenic BRI2-Abeta mice","volume":"8","author":"Kim","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib39","doi-asserted-by":"crossref","first-page":"E106","DOI":"10.1152\/ajpendo.00279.2018","article-title":"Ablation of amyloid precursor protein increases insulin Degrading enzyme levels and activity in brain and peripheral tissues","volume":"316","author":"Kulas","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib40","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.2174\/13816128113199990711","article-title":"beta-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease","volume":"19","author":"Kuznetsova","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib41","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.nicl.2014.03.005","article-title":"Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology","volume":"4","author":"Laforce","year":"2014","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib42","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.neurobiolaging.2009.07.002","article-title":"Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI","volume":"32","author":"Landau","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib43","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3892\/mmr.2013.1404","article-title":"Alzheimer's phenotypes induced by overexpression of human presenilin 2 mutant proteins stimulate significant changes in key factors of glucose metabolism","volume":"7","author":"Lee","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib44","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jalz.2017.11.008","article-title":"Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease. Alzheimer's & dementia","volume":"14","author":"Leuzy","year":"2018","journal-title":"J.\u00a0Alzheimers Assoc."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib45","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1096\/fj.06-6463fje","article-title":"Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer's disease mouse models","volume":"20","author":"Levites","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib46","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ijo.2013.86","article-title":"Identification of optimal reference genes for RT-qPCR in the rat hypothalamus and intestine for the study of obesity","volume":"38","author":"Li","year":"2014","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib47","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.freeradbiomed.2017.07.024","article-title":"Activation of brain glucose metabolism ameliorating cognitive impairment in APP\/PS1 transgenic mice by electroacupuncture","volume":"112","author":"Liu","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.febslet.2007.12.035","article-title":"Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease","volume":"582","author":"Liu","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib49","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.bbi.2011.06.009","article-title":"Ursolic acid improves high fat diet-induced cognitive impairments by blocking endoplasmic reticulum stress and IkappaB kinase beta\/nuclear factor-kappaB-mediated inflammatory pathways in mice","volume":"25","author":"Lu","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib50","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0026-0495(93)90004-8","article-title":"Insulin therapy normalizes GLUT1 glucose transporter mRNA but not immunoreactive transporter protein in streptozocin-diabetic rats","volume":"42","author":"Lutz","year":"1993","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2019.03.016","article-title":"Understanding the link between insulin resistance and Alzheimer's disease: Insights from animal models","volume":"316","author":"Lyra E Silva","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib52","doi-asserted-by":"crossref","first-page":"17495","DOI":"10.1074\/jbc.M115.660498","article-title":"Signaling through the phosphatidylinositol 3-kinase (PI3K)\/mammalian target of rapamycin (mTOR) axis is responsible for aerobic glycolysis mediated by glucose transporter in Epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma","volume":"290","author":"Makinoshima","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib53","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1590\/1980-57642016dn11-040010","article-title":"Association between diabetes and causes of dementia: evidence from a clinicopathological study","volume":"11","author":"Matioli","year":"2017","journal-title":"Dement Neuropsychol."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib54","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1073\/pnas.79.17.5406","article-title":"Metabolic fuel and amino acid transport into the brain in experimental diabetes mellitus","volume":"79","author":"McCall","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib55","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.brainres.2012.02.041","article-title":"The levels of water-soluble and triton-soluble Abeta are increased in Alzheimer's disease brain","volume":"1450","author":"McDonald","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib56","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuron.2005.06.030","article-title":"Abeta42 is essential for parenchymal and vascular amyloid deposition in mice","volume":"47","author":"McGowan","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib57","doi-asserted-by":"crossref","first-page":"e00094","DOI":"10.1042\/AN20120044","article-title":"Metabotropic glutamate receptors inhibit microglial glutamate release","volume":"4","author":"McMullan","year":"2012","journal-title":"ASN Neuro."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib58","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00401-011-0834-y","article-title":"Vascular beta-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAbeta mice","volume":"122","author":"Merlini","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib59","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1096\/fj.201700400RR","article-title":"EGCG ameliorates high-fat- and high-fructose-induced cognitive defects by regulating the IRS\/AKT and ERK\/CREB\/BDNF signaling pathways in the CNS","volume":"31","author":"Mi","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib61","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00000441-199103000-00004","article-title":"Brain uptake of glucose in diabetes mellitus: the role of glucose transporters","volume":"301","author":"Mooradian","year":"1991","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib62","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/000331979304400802","article-title":"Analysis of familial and individual risk factors among patients with ischemic vascular dementia and Alzheimer's disease","volume":"44","author":"Mortel","year":"1993","journal-title":"Angiology"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/path.2343","article-title":"Identification of the Alzheimer's disease amyloid precursor protein (APP) and its homologue APLP2 as essential modulators of glucose and insulin homeostasis and growth","volume":"215","author":"Needham","year":"2008","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib64","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1212\/WNL.0b013e31822f0435","article-title":"Glucose tolerance status and risk of dementia in the community: the Hisayama study","volume":"77","author":"Ohara","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib65","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1083\/jcb.201403080","article-title":"Glucose uptake in brown fat cells is dependent on mTOR complex 2-promoted GLUT1 translocation","volume":"207","author":"Olsen","year":"2014","journal-title":"J.\u00a0Cell Biol"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib66","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1093\/cercor\/bht076","article-title":"Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function?","volume":"24","author":"Ossenkoppele","year":"2014","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnagi.2019.00043","article-title":"High cortisol and the risk of dementia and Alzheimer's disease: a review of the literature","volume":"11","author":"Ouanes","year":"2019","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib68","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1152\/physiolgenomics.00139.2006","article-title":"Novel method for high-throughput phenotyping of sleep in mice","volume":"28","author":"Pack","year":"2007","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib69","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jalz.2017.07.754","article-title":"Apolipoprotein E4 inhibits autophagy gene products through direct, specific binding to CLEAR motifs","volume":"14","author":"Parcon","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib70","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.2337\/diab.39.9.1040","article-title":"Downregulation of blood-brain barrier glucose transporter in experimental diabetes","volume":"39","author":"Pardridge","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib71","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","article-title":"Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study","volume":"51","author":"Peila","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib72","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/nan.12476","article-title":"Review: Relationship of type 2 diabetes to human brain pathology","volume":"44","author":"Pruzin","year":"2018","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib73","first-page":"41","article-title":"Diabetes, hemoglobin A1C, and regional Alzheimer disease and infarct pathology","volume":"31","author":"Pruzin","year":"2017","journal-title":"Alzheimer Dis."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib74","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2337\/dc08-0272","article-title":"Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study","volume":"32","author":"Raffaitin","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib75","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2337\/db16-0917","article-title":"Brain GLUT4 Knockout mice have impaired glucose tolerance, decreased insulin sensitivity, and impaired hypoglycemic counterregulation","volume":"66","author":"Reno","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib76","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2967\/jnumed.113.132647","article-title":"Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation","volume":"55","author":"Roberts","year":"2014","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib77","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/jcbfm.2009.36","article-title":"Neuroinflammation extends brain tissue at risk to vital peri-infarct tissue: a double tracer [11C]PK11195- and [18F]FDG-PET study","volume":"29","author":"Schroeter","year":"2009","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib78","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3233\/JAD-151101","article-title":"Impaired autophagy in APOE4 astrocytes","volume":"51","author":"Simonovitch","year":"2016","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib79","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ana.410350507","article-title":"Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease","volume":"35","author":"Simpson","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib80","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1471-4159.1977.tb03919.x","article-title":"Relation between physiological function and energy metabolism in the central nervous system","volume":"29","author":"Sokoloff","year":"1977","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib81","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-9384(00)00380-2","article-title":"Acute hypoglycemia impairs the functioning of the central but not peripheral nervous system","volume":"72","author":"Strachan","year":"2001","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib82","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/jamaneurol.2013.284","article-title":"Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging","volume":"70","author":"Thambisetty","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib83","doi-asserted-by":"crossref","first-page":"e12919","DOI":"10.1111\/acel.12919","article-title":"Tau underlies synaptic and cognitive deficits for type 1, but not type 2 diabetes mouse models","volume":"18","author":"Trujillo-Estrada","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib84","doi-asserted-by":"crossref","first-page":"e1003107","DOI":"10.1371\/journal.pgen.1003107","article-title":"Integrative analysis of a cross-loci regulation network identifies App as a gene regulating insulin secretion from pancreatic islets","volume":"8","author":"Tu","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib85","first-page":"E179","article-title":"Cold exposure potentiates the effect of insulin on in\u00a0vivo glucose uptake","volume":"253","author":"Vallerand","year":"1987","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib86","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s004010050872","article-title":"Comparison of beta-protein\/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer's disease patients: amorphic plaques and cytoskeletal changes occur independently","volume":"96","author":"van de Nes","year":"1998","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib87","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00401-005-0018-8","article-title":"Beta-protein\/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients","volume":"111","author":"van de Nes","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib88","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C","article-title":"Glucose transporter proteins in brain: delivery of glucose to neurons and glia","volume":"21","author":"Vannucci","year":"1997","journal-title":"Glia"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib89","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00702-019-01975-4","article-title":"Dementia spectrum disorders: lessons learnt from decades with PET research","volume":"126","author":"Wilson","year":"2019","journal-title":"J.\u00a0Neural Transm. (Vienna)"},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib90","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nn.3966","article-title":"GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration","volume":"18","author":"Winkler","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib91","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3171\/2011.3.JNS10899","article-title":"Relation between brain interstitial and systemic glucose concentrations after subarachnoid hemorrhage","volume":"115","author":"Zetterling","year":"2011","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.neurobiolaging.2020.10.001_bib92","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nn.4492","article-title":"[(18)F]FDG PET signal is driven by astroglial glutamate transport","volume":"20","author":"Zimmer","year":"2017","journal-title":"Nat. Neurosci."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458020303109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458020303109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:35:48Z","timestamp":1759318548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458020303109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":92,"alternative-id":["S0197458020303109"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.10.001","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alzheimer amyloid-\u03b2- peptide disrupts membrane localization of glucose transporter 1 in astrocytes: implications for glucose levels in brain and blood","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}